834 related articles for article (PubMed ID: 28049043)
21. Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.
Schlezinger JJ; Puckett H; Oliver J; Nielsen G; Heiger-Bernays W; Webster TF
Toxicol Appl Pharmacol; 2020 Oct; 405():115204. PubMed ID: 32822737
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR.
Elcombe CR; Elcombe BM; Foster JR; Chang SC; Ehresman DJ; Butenhoff JL
Toxicology; 2012 Mar; 293(1-3):16-29. PubMed ID: 22245121
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
[TBL] [Abstract][Full Text] [Related]
24. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice.
Wolf DC; Moore T; Abbott BD; Rosen MB; Das KP; Zehr RD; Lindstrom AB; Strynar MJ; Lau C
Toxicol Pathol; 2008 Jun; 36(4):632-9. PubMed ID: 18467680
[TBL] [Abstract][Full Text] [Related]
25. Developmental toxicity of perfluorononanoic acid in mice.
Das KP; Grey BE; Rosen MB; Wood CR; Tatum-Gibbs KR; Zehr RD; Strynar MJ; Lindstrom AB; Lau C
Reprod Toxicol; 2015 Jan; 51():133-44. PubMed ID: 25543169
[TBL] [Abstract][Full Text] [Related]
26. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
27. Effect of prenatal PFOS exposure on liver cell function in neonatal mice.
Liang X; Xie G; Wu X; Su M; Yang B
Environ Sci Pollut Res Int; 2019 Jun; 26(18):18240-18246. PubMed ID: 31041707
[TBL] [Abstract][Full Text] [Related]
28. Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression.
Bjork JA; Lau C; Chang SC; Butenhoff JL; Wallace KB
Toxicology; 2008 Sep; 251(1-3):8-20. PubMed ID: 18692542
[TBL] [Abstract][Full Text] [Related]
29. Perfluorinated alkyl acids in the serum and follicular fluid of UK women with and without polycystic ovarian syndrome undergoing fertility treatment and associations with hormonal and metabolic parameters.
Heffernan AL; Cunningham TK; Drage DS; Aylward LL; Thompson K; Vijayasarathy S; Mueller JF; Atkin SL; Sathyapalan T
Int J Hyg Environ Health; 2018 Aug; 221(7):1068-1075. PubMed ID: 30037723
[TBL] [Abstract][Full Text] [Related]
30. Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging.
Kim SM; Lee B; An HJ; Kim DH; Park KC; Noh SG; Chung KW; Lee EK; Kim KM; Kim DH; Kim SJ; Chun P; Lee HJ; Moon HR; Chung HY
Oncotarget; 2017 Jul; 8(28):46273-46285. PubMed ID: 28545035
[TBL] [Abstract][Full Text] [Related]
31. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
[TBL] [Abstract][Full Text] [Related]
32. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Hox and ParaHox genes by perfluorochemicals in mouse liver.
Zhang Y; Le Y; Bu P; Cheng X
Toxicology; 2020 Aug; 441():152521. PubMed ID: 32534105
[TBL] [Abstract][Full Text] [Related]
34. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
[TBL] [Abstract][Full Text] [Related]
35. Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.
Pant A; Rondini EA; Kocarek TA
Toxicol Appl Pharmacol; 2019 Feb; 365():61-70. PubMed ID: 30611723
[TBL] [Abstract][Full Text] [Related]
36. Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Komatsu M; Kimura T; Yazaki M; Tanaka N; Yang Y; Nakajima T; Horiuchi A; Fang ZZ; Joshita S; Matsumoto A; Umemura T; Tanaka E; Gonzalez FJ; Ikeda S; Aoyama T
Biochim Biophys Acta; 2015 Mar; 1852(3):473-81. PubMed ID: 25533124
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of perfluoroalkyl acid activity using primary mouse and human hepatocytes.
Rosen MB; Das KP; Wood CR; Wolf CJ; Abbott BD; Lau C
Toxicology; 2013 Jun; 308():129-37. PubMed ID: 23567314
[TBL] [Abstract][Full Text] [Related]
39. Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines.
Fang X; Zou S; Zhao Y; Cui R; Zhang W; Hu J; Dai J
Arch Toxicol; 2012 Oct; 86(10):1515-25. PubMed ID: 22648072
[TBL] [Abstract][Full Text] [Related]
40. Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds.
Wolf CJ; Schmid JE; Lau C; Abbott BD
Reprod Toxicol; 2012 Jul; 33(4):546-551. PubMed ID: 22107727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
